All Posts: non-small cell lung cancer

• Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers With ALK Mutations

  Early signals from phase 1 of the ALKOVE-1 clinical trial suggest potential benefit from the use of an investigational drug called NVL-655 in people whose non-small cell lung cancer has alterations in a gene called ALK.

  Category: News Release Tags: cancer, clinical trials, gene sequencing, non-small cell lung cancer

• FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research

  (September 14, 2020) — Julie Shanholtz was having an uneventful summer in 2017 working full time with the same employer she’d had for the past 30 years when she developed an “odd cough” that quickly became severe, but no other symptoms. “I had always been very active and healthy — and didn’t smoke,” the 54-year-old […]

  Category: Lombardi Stories Tags: cancer, cancer research, clinical trials, lung cancer, non-small cell lung cancer